Lehre & Forschung
BIOSIGNAL
-
Biomarker signature of stroke aetiology study.
Status: current, recruiting completed
CAPSAICIN
-
Capsaicin for post-stroke dysphagia (CADYS). The aim of this multicenter, randomizes, double-blind study is to examine the effect of Capsaicin treatment in the setting of (sub-)acute stroke, compared to placebo.
Status: planned
CISS
-
Effects of serotonergic neuromodulation on behavioural recovery and motor network plasticity after cortical ischemic stroke: a longitudinal, placebo-controlled study.
Status: current
ECST
-
The 2nd European Carotid Surgery Trial.
Status: planned
ELAN
-
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised-controlled, two-arm, assessor-blinded Trial.
Status: current
eSATIS
-
Early Sleep Apnea Treatment in Stroke: A Randomized, Rater-Blinded, Clinical Trial of Adaptive Servo-Ventilation.
Status: current
ESTREL
-
Enhancement of Stroke Rehabilitation with Levodopa (ESTREL): a randomized placebo-controlled Trial.
Status: planned
Swiss Stroke Registry (SSR)
-
Schweizweite Datenbank zum akuten Schlaganfall.
Status: current
TICH NOAC
-
Treatment of intracerebral hemorrhage in patients on non-vitamin K oral anticoagulants with tranexamic acid.
Status: current
TREAT-CAD
-
Biomarker und antithrombotische Therapie bei Dissektion der hirnzuführenden Gefässe (TREAT-CAD).
Status: current, recruiting completed
Informieren Sie sich über die Forschungsaktivitäten des Kantonsspitals St.Gallen und melden Sie Probandinnen und Probanden für Studien an: